mRNA Therapeutics Market Size, Share & Trends Report

mRNA Therapeutics Market Size, Share & Trends Analysis Report By Application (Rare Genetic Diseases, Oncology, Respiratory Diseases, Infectious Diseases), By Type (Prophylactic, Therapeutic), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68039-957-3
Number of Pages: 120
Format: Electronic (PDF)

Historical Range: 2018 - 2023
Industry: Healthcare

Market Segmentation

mRNA Therapeutics Type Outlook (Revenue, USD Million, 2018 - 2030)
- Prophylactic
- Therapeutic
mRNA Therapeutics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Infectious Diseases
- Oncology
- Rare Genetic Diseases
- Respiratory Diseases
- Others
mRNA Therapeutics End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals & Clinics
- Research Organizations
- Others
mRNA Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America mRNA Therapeutics Market, By Type
    - Prophylactic
    - Therapeutic
  - North America mRNA Therapeutics Market, By Application
    - Infectious Diseases
    - Oncology
    - Rare Genetic Diseases
    - Respiratory Diseases
    - Others
  - North America mRNA Therapeutics Market, By End-use
    - Hospitals & Clinics
    - Research Organizations
    - Others
  - U.S.
    - U.S. mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - U.S. mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - U.S. mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Canada
    - Canada mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Canada mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Canada mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
- Europe
  - Europe mRNA Therapeutics Market, By Type
    - Prophylactic
    - Therapeutic
  - Europe mRNA Therapeutics Market, By Application
    - Infectious Diseases
    - Oncology
    - Rare Genetic Diseases
    - Respiratory Diseases
    - Others
  - Europe mRNA Therapeutics Market, By End-use
    - Hospitals & Clinics
    - Research Organizations
    - Others
  - UK
    - UK mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - UK mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - UK mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Germany
    - Germany mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Germany mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Germany mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - France
    - France mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - France mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - France mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Italy
    - Italy mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Italy mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Italy mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Spain
    - Spain mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Spain mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Spain mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Denmark
    - Denmark mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Denmark mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Denmark mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Sweden
    - Sweden mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Sweden mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Sweden mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Norway
    - Norway mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Norway mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Norway mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
- Asia Pacific
  - Asia Pacific mRNA Therapeutics Market, By Type
    - Prophylactic
    - Therapeutic
  - Asia Pacific mRNA Therapeutics Market, By Application
    - Infectious Diseases
    - Oncology
    - Rare Genetic Diseases
    - Respiratory Diseases
    - Others
  - Asia Pacific mRNA Therapeutics Market, By End-use
    - Hospitals & Clinics
    - Research Organizations
    - Others
  - China
    - China mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - China mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - China mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Japan
    - Japan mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Japan mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Japan mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - India
    - India mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - India mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - India mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Australia
    - Australia mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Australia mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Australia mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Thailand
    - Thailand mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Thailand mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Thailand mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - South Korea
    - South Korea mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - South Korea mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - South Korea mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
- Latin America
  - Latin America mRNA Therapeutics Market, By Type
    - Prophylactic
    - Therapeutic
  - Latin America mRNA Therapeutics Market, By Application
    - Infectious Diseases
    - Oncology
    - Rare Genetic Diseases
    - Respiratory Diseases
    - Others
  - Latin America mRNA Therapeutics Market, By End-use
    - Hospitals & Clinics
    - Research Organizations
    - Others
  - Brazil
    - Brazil mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Brazil mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Brazil mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Mexico
    - Mexico mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Mexico mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Mexico mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Argentina
    - Argentina mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Argentina mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Argentina mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
- Middle East & Africa
  - Middle East & Africa mRNA Therapeutics Market, By Type
    - Prophylactic
    - Therapeutic
  - Middle East & Africa mRNA Therapeutics Market, By Application
    - Infectious Diseases
    - Oncology
    - Rare Genetic Diseases
    - Respiratory Diseases
    - Others
  - Middle East & Africa mRNA Therapeutics Market, By End-use
    - Hospitals & Clinics
    - Research Organizations
    - Others
  - South Africa
    - South Africa mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - South Africa mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - South Africa mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Saudi Arabia
    - Saudi Arabia mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Saudi Arabia mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Saudi Arabia mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - UAE
    - UAE mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - UAE mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - UAE mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others
  - Kuwait
    - Kuwait mRNA Therapeutics Market, By Type
      - Prophylactic
      - Therapeutic
    - Kuwait mRNA Therapeutics Market, By Application
      - Infectious Diseases
      - Oncology
      - Rare Genetic Diseases
      - Respiratory Diseases
      - Others
    - Kuwait mRNA Therapeutics Market, By End-use
      - Hospitals & Clinics
      - Research Organizations
      - Others

mRNA Therapeutics Market Dynamics

Driver: Rising Prevalence of Cancer

The incidence of cancer is rising globally, surpassing cardiovascular disease as the second greatest cause of death. This can be attributed to environmental reasons, including cigarette use, urbanization, growing pollution, changing dietary habits, and more affluence brought on by improved healthcare & an increase in postreproductive life duration. In addition, age-related risk accumulation for particular cancers is most likely the cause of the sharp rise in cancer incidence. Moreover, lung, breast, colon & rectum, stomach, liver, and hepatitis C are among the main cancers that cause death. Hence, growing sedentary life, increasing geriatric population, and others are a few factors improving the demand for mRNA Cancer therapeutics, propelling market growth over the forecast period. Furthermore, the consumption of alcohol and tobacco is surging across the globe.

According to WHO, tobacco use, a high body mass index, alcohol usage, a low intake of fruits & vegetables, and a lack of physical activity account for about one-third of cancer-related fatalities. Consequently, there is a greater need for mRNA cancer treatments. In addition, the lack of precision cancer therapy medications is pressuring the government and several leading players to invest extensively in R&D. Hence, the demand for mRNA cancer treatments is rising, driving market growth over the forecast period.

Driver: Academic and Industrial Interest in mRNA

Recently, RNA centers have been established at numerous institutions to promote therapeutic uses for RNA, particularly in Vitro Transcribed (IVT) mRNA. These facilities include the Yale Center for RNA Science & Medicine, the RNA Institute at the University at Albany, the State University of New York, and the RNA Therapeutic Institute at the University of Massachusetts in the U.S.

In addition, university spin-off businesses funded by significant venture capital infusions (such as Argos Medicines, Factor Bioscience, CureVac, Ethris, BioNTech, Moderna, eTheRNA, and Onkaido) have advanced the preclinical and clinical development of mRNA-based therapeutics. Moreover, the testing of mRNA treatment is being done to encourage the development of new blood vessels. For instance, Moderna and AstraZeneca are working together on a myocardial ischemia therapy using mRNA (a form of cardiac disease that develops when there is a decrease in blood flow to the heart, depriving the heart muscle of necessary oxygen). Similarly, mRNA treatments for heart disease are being tested by Arcturus Therapeutics. Hence, several major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire.

Restraint: Stringent Government Regulations for mRNA-Based Product Approvals

The regulatory framework for approval processes has always been the most critical restraining factor in the pharmaceutical, biotechnology, and medical technology industries. The absence of effective regulatory framework/guidelines for the therapeutic sector in developing countries, such as China and India, where the mRNA therapeutics market holds immense growth potential due to a large patient base, is anticipated to impede market growth in the coming decade.

Such a discrete & uncertain scenario about the regulations for vaccines & therapeutics approval creates confusion among manufacturers regarding the commercialization of mRNA-based products. Moreover, in certain cases, POC for primary care practices are not properly resourced for reimbursements. The reimbursement structure varies in every region. For instance, different reimbursement structures exist across Europe with varied benefits and risks. This factor is expected to decrease the adoption of mRNA-based products among manufacturers.

What Does This Report Include?

This section will provide insights into the contents included in this mRNA therapeutics market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

mRNA Therapeutics market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

mRNA Therapeutics market quantitative analysis

Market size, estimates, and forecast from 2020 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.